Literature DB >> 22983577

Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.

Olivier Lambotte1, Bénédicte Neven, Lionel Galicier, Aude Magerus-Chatinet, Nicolas Schleinitz, Olivier Hermine, Isabelle Meyts, Capucine Picard, Bertrand Godeau, Alain Fischer, Frédéric Rieux-Laucat.   

Abstract

A diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency during adulthood is unusual. We analyzed 17 cases of autoimmune lymphoproliferative syndrome caused by FAS deficiency diagnosed during adulthood in French reference centers for hereditary immunodeficiencies and for immune cytopenias. Twelve of the 17 patients had developed their first symptoms during childhood. The diagnosis of autoimmune lymphoproliferative syndrome had been delayed for a variety of reasons, including unusual clinical manifestations, late referral to a reference center, and the occurrence of somatic FAS mutations. The 5 other patients presented their first symptoms after the age of 16 years. In these patients, three germline heterozygous FAS mutations were predicted to be associated with haploinsufficiency and a somatic event on the second FAS allele was observed in 2 cases. Autoimmune lymphoproliferative syndrome may well be diagnosed in adulthood. The occurrence of additional genetic events may account for the delayed disease onset.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983577      PMCID: PMC3659930          DOI: 10.3324/haematol.2012.067488

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  11 in total

1.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Authors:  Joao B Oliveira; Jack J Bleesing; Umberto Dianzani; Thomas A Fleisher; Elaine S Jaffe; Michael J Lenardo; Frederic Rieux-Laucat; Richard M Siegel; Helen C Su; David T Teachey; V Koneti Rao
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.

Authors:  Aude Magerus-Chatinet; Bénédicte Neven; Marie-Claude Stolzenberg; Cécile Daussy; Peter D Arkwright; Nina Lanzarotti; Catherine Schaffner; Sophie Cluet-Dennetiere; Filomeen Haerynck; Gérard Michel; Christine Bole-Feysot; Mohammed Zarhrate; Isabelle Radford-Weiss; Serge P Romana; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

3.  FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.

Authors:  Hye Sun Kuehn; Iusta Caminha; Julie E Niemela; V Koneti Rao; Joie Davis; Thomas A Fleisher; João B Oliveira
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

4.  Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.

Authors:  Kennichi C Dowdell; Julie E Niemela; Susan Price; Joie Davis; Ronald L Hornung; João Bosco Oliveira; Jennifer M Puck; Elaine S Jaffe; Stefania Pittaluga; Jeffrey I Cohen; Thomas A Fleisher; V Koneti Rao
Journal:  Blood       Date:  2010-04-01       Impact factor: 22.113

5.  Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.

Authors:  Iusta Caminha; Thomas A Fleisher; Ronald L Hornung; Janet K Dale; Julie E Niemela; Susan Price; Joie Davis; Katie Perkins; Kennichi C Dowdell; Margaret R Brown; V Koneti Rao; João Bosco Oliveira
Journal:  J Allergy Clin Immunol       Date:  2010-03-15       Impact factor: 10.793

6.  Clinical, immunological, and pathological consequences of Fas-deficient conditions.

Authors:  F Le Deist; J F Emile; F Rieux-Laucat; M Benkerrou; I Roberts; N Brousse; A Fischer
Journal:  Lancet       Date:  1996-09-14       Impact factor: 79.321

7.  FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.

Authors:  Aude Magerus-Chatinet; Marie-Claude Stolzenberg; Maria S Loffredo; Bénédicte Neven; Catherine Schaffner; Nicolas Ducrot; Peter D Arkwright; Brigitte Bader-Meunier; José Barbot; Stéphane Blanche; Jean-Laurent Casanova; Marianne Debré; Alina Ferster; Claire Fieschi; Benoit Florkin; Claire Galambrun; Olivier Hermine; Olivier Lambotte; Eric Solary; Caroline Thomas; Francoise Le Deist; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat
Journal:  Blood       Date:  2009-01-27       Impact factor: 22.113

8.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood.

Authors:  M Deutsch; E Tsopanou; S P Dourakis
Journal:  Clin Rheumatol       Date:  2003-12-20       Impact factor: 2.980

10.  Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.

Authors:  Elisa Cerutti; Maria F Campagnoli; Massimo Ferretti; Emanuela Garelli; Nicoletta Crescenzio; Angelo Rosolen; Annalisa Chiocchetti; Michael J Lenardo; Ugo Ramenghi; Umberto Dianzani
Journal:  BMC Immunol       Date:  2007-11-13       Impact factor: 3.615

View more
  9 in total

1.  An atypical case of late-onset systemic lupus erythematosus with systemic lymphadenopathy and severe autoimmune thrombocytopenia/neutropenia mimicking malignant lymphoma.

Authors:  Keita Tamaki; Satoko Morishima; Sawako Nakachi; Sakiko Kitamura; Sachie Uchibori; Shouhei Tomori; Taeko Hanashiro; Natsuki Shimabukuro; Iori Tedokon; Kazuho Morichika; Yukiko Nishi; Takeaki Tomoyose; Kennosuke Karube; Takuya Fukushima; Hiroaki Masuzaki
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

Review 2.  The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.

Authors:  Frédéric Rieux-Laucat; Aude Magérus-Chatinet; Bénédicte Neven
Journal:  J Clin Immunol       Date:  2018-06-17       Impact factor: 8.317

3.  Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.

Authors:  Schafiq Nabhani; Sebastian Ginzel; Hagit Miskin; Shoshana Revel-Vilk; Dan Harlev; Bernhard Fleckenstein; Andrea Hönscheid; Prasad T Oommen; Michaela Kuhlen; Ralf Thiele; Hans-Jürgen Laws; Arndt Borkhardt; Polina Stepensky; Ute Fischer
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941

Review 4.  Autoimmune lymphoproliferative syndrome: an update and review of the literature.

Authors:  Shaili Shah; Eveline Wu; V Koneti Rao; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2014-09       Impact factor: 4.806

5.  Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Authors:  Dita Gratzinger; Elaine S Jaffe; Amy Chadburn; John K C Chan; Daphne de Jong; John R Goodlad; Jonathan Said; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

6.  Unexplained lymphadenopathies: autoimmune lymphoproliferative syndrome in an adult patient.

Authors:  Fatima Leal-Seabra; Gonçalo Sarmento Costa; Henrique Pereira Coelho; Agripino Oliveira
Journal:  BMJ Case Rep       Date:  2016-12-15

Review 7.  Monogenic Adult-Onset Inborn Errors of Immunity.

Authors:  Frederik Staels; Tom Collignon; Albrecht Betrains; Margaux Gerbaux; Mathijs Willemsen; Stephanie Humblet-Baron; Adrian Liston; Steven Vanderschueren; Rik Schrijvers
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

8.  Increased double-negative αβ+ T-cells reveal adult-onset autoimmune lymphoproliferative syndrome in a patient with IgG4-related disease.

Authors:  Nivaz Brar; Michael A Spinner; Matthew C Baker; Ranjana H Advani; Yasodha Natkunam; David B Lewis; Oscar Silva
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941

Review 9.  ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.

Authors:  Filippo Consonni; Eleonora Gambineri; Claudio Favre
Journal:  Ann Hematol       Date:  2022-01-20       Impact factor: 3.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.